[Exendin-4 protected murine MIN6 pancreatic beta-cells from oxidative stress-induced apoptosis via down-regulation of NF-kappaB-iNOS-NO pathway]

Yao Xue Xue Bao. 2008 Jul;43(7):690-4.
[Article in Chinese]

Abstract

To explore the effect of glucagon-like peptide-1 receptor agonist--Exendin-4 (Ex-4) on murine MIN6 pancreatic beta-cells apoptosis induced by oxidative stress, the morphological changes of cell damage were evaluated by epifluorescence microscopy after staining with AO-EB. The percentage of cell apoptosis was determined by flow cytometric assay after Annexin-V-FITC-PI staining. Nitric oxide level was measured by Griess reagent assay. Inducible nitric oxide synthase (iNOS) protein and NF-kappaBp65 fragment were detected by Western blotting. Ex-4 inhibited the increase of nitrite level and percentage of apoptosis induced by t-BHP in MIN6 cells. Furthermore, Ex-4 partly reduced the expression of iNOS protein and the ratio of NF-kappaBp65 protein in nucleus:cytosol induced by t-BHP. These results suggest that Ex4 protects MIN6 pancreatic kappa-cells from oxidative stress-induced apoptosis via down-regulation of NF-kappaB-iNOS-nitric oxide pathway.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / drug effects*
  • Down-Regulation
  • Exenatide
  • Glucagon-Like Peptide-1 Receptor
  • Hypoglycemic Agents / pharmacology
  • Incretins / agonists
  • Insulin-Secreting Cells / cytology*
  • Insulin-Secreting Cells / metabolism
  • Lizards
  • Mice
  • Nitric Oxide / metabolism*
  • Nitric Oxide Synthase Type II / metabolism*
  • Oxidative Stress / drug effects
  • Peptides / pharmacology*
  • Receptors, Glucagon / agonists
  • Signal Transduction
  • Transcription Factor RelA / metabolism*
  • Venoms / pharmacology*
  • tert-Butylhydroperoxide / pharmacology

Substances

  • Glp1r protein, mouse
  • Glucagon-Like Peptide-1 Receptor
  • Hypoglycemic Agents
  • Incretins
  • Peptides
  • Receptors, Glucagon
  • Transcription Factor RelA
  • Venoms
  • Nitric Oxide
  • tert-Butylhydroperoxide
  • Exenatide
  • Nitric Oxide Synthase Type II